These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11405553)

  • 1. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot.
    Matalliotakis IM; Athanassakis I; Goumenou AG; Neonaki MA; Koumantakis EE; Vassiliadis S; Koumantakis EE
    Mediators Inflamm; 2001 Apr; 10(2):75-80. PubMed ID: 11405553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis.
    Matalliotakis IM; Arici A; Goumenou AG; Katassos T; Karkavitsas N; Koumantakis EE
    Int J Fertil Womens Med; 2004; 49(2):75-8. PubMed ID: 15188832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial.
    Crosignani PG; Gastaldi A; Lombardi PL; Montemagno U; Vignali M; Serra GB; Stella C
    Clin Ther; 1992; 14 Suppl A():29-36. PubMed ID: 1535020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments.
    Matalliotakis IM; Koumantaki YG; Neonaki MA; Goumenou AG; Koumantakis GE; Kyriakou DS; Koumantakis EE
    Am J Obstet Gynecol; 2000 Jul; 183(1):58-62. PubMed ID: 10920309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment.
    Matalliotakis IM; Vassiliadis S; Goumenou AG; Athanassakis I; Koumantakis GE; Neonaki MA; Koumantakis EE
    J Reprod Immunol; 2001 Jul; 51(1):9-19. PubMed ID: 11438377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
    Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis.
    Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):431-7. PubMed ID: 8803306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
    Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
    Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis.
    Matalliotakis I; Neonaki M; Zolindaki A; Hassan E; Georgoulias V; Koumantakis E
    Int J Fertil Womens Med; 1997; 42(3):211-4. PubMed ID: 9222806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and identification of soluble HLA-G isoforms.
    Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SHBG serum level in women with endometriosis before, during and after long-term danazol therapy].
    Panidis D; Kokkinos T; Vavilis D; Rousso D; Tantanassis T; Kalogeropoulos A
    Geburtshilfe Frauenheilkd; 1993 Feb; 53(2):121-4. PubMed ID: 8462828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
    Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
    Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis.
    Mach P; Blecharz P; Basta P; Marianowski P; Skret-Magierlo J; Kojs Z; Grabiec M; Wicherek L
    Am J Reprod Immunol; 2010 May; 63(5):387-95. PubMed ID: 20146732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced endometriosis treatment with leuprolide acetate].
    Valdés P; Sierralta P
    Rev Chil Obstet Ginecol; 1993; 58(5):405-10. PubMed ID: 7991863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
    Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
    Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol].
    Palagiano A; Capuano V
    Minerva Ginecol; 1994 Apr; 46(4):173-7. PubMed ID: 8065590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis.
    Rotondi M; Labriola D; Rotondi M; Ammaturo FP; Amato G; Carella C; Izzo A; Panariello S
    Eur J Gynaecol Oncol; 2002; 23(6):523-6. PubMed ID: 12556096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility gene products and human immunodeficiency virus infection.
    Puppo F; Ruzzenenti R; Brenci S; Lanza L; Scudeletti M; Indiveri F
    J Lab Clin Med; 1991 Feb; 117(2):91-100. PubMed ID: 1993862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.